Pfizer

American multinational pharmaceutical and biotechnology corporation

PFE NYSE ISIN US7170811035 SEC CIK 78003 LEI 765LHXWGK1KXCLTFYQ30
Follow Pfizer Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $16.6B −0.4% vs same quarter last year
Net income $3.2B −8.4% vs same quarter last year
EPS, diluted $0.56 −9.7% vs same quarter last year
Operating cash flow $5.4B +16.8% vs same quarter last year
Revenue by quarter
$17.8B
$13.7B
$14.7B
$16.7B
$17.6B
$14.5B
$15B
$16.6B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$25B$50B$75B$100BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$62.6B$7.8B
FY24$63.6B$8B
FY23$50.9B$2.1B
FY22$91.8B$31.4B
FY21$73.6B$22B
FY20$41.7B$9.2B
FY19$40.9B$16B
FY18$40.8B$11.2B
FY17$52.5B$21.3B
FY16$52.8B$7.2B
FY15$48.9B$7B
FY14$49.6B$9.1B
FY13$51.6B$22B
FY12$54.7B$14.6B
FY11$61B$10B
MarginsShare of revenue
  • Gross margin
  • Net margin
0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginNet margin
FY2574.3%12.4%
FY2471.9%12.6%
FY2351%4.2%
FY2262.6%34.2%
FY2158.1%29.8%
FY2079.6%22%
FY1980.3%39.2%
FY1878%27.3%
FY1778.6%40.6%
FY1676.7%13.7%
FY1580.3%14.2%
FY1480.7%18.4%
FY1381.4%42.7%
FY1282%26.7%
FY1179.5%16.4%
Free cash flowOperating cash flow minus capital expenditure
$0$10B$20B$30BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$9.1B
FY24$9.8B
FY23$4.8B
FY22$26B
FY21$29.9B
FY20$12.2B
FY19$10.5B
FY18$13.8B
FY17$14.8B
FY16$14.4B
FY15$13.3B
FY14$15.9B
FY13$16.5B
FY12$15.4B
FY11$18.6B
Returned to shareholdersDividends paid and shares bought back
$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24$0
FY23$0
FY22$2B
FY21$0
FY20$0
FY19$8.9B
FY18$12.2B
FY17$5B
FY16$5B
FY15$6.2B
FY14$5B
FY13$16.3B
FY12$8.2B
FY11$9B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Pfizer
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPfizerHealthcare median
FY2512.4%−30.6%
FY2412.6%−47%
FY234.2%−58%
FY2234.2%−80.4%
FY2129.8%−71.9%
FY2022%−62.2%
FY1939.2%−46.3%
FY1827.3%−49.6%
FY1740.6%−45.9%
FY1613.7%−36%
FY1514.2%−38.4%
FY1418.4%−35.5%
FY1342.7%−37.1%
FY1226.7%−29.1%
FY1116.4%−27.9%